Delivery Order SPE2DB24D2011-SPE2DB24FBPWZ
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order valued at $4,434.96 for the provision of Advair HFA 230-21 mcg inhalers. The contract has a completion date of April 29, 2024 and is structured as a Firm Fixed Price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $4,113.24 with a completion date of January 2, 2025. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the provision of Advair HFA 230-21 MCG Inhaler 12GM. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,222.83 firm-fixed-price delivery order is for the supply of Advair HFA 230-21 mcg inhalers, a prescription medication, to DLA facilities. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,671.96 delivery order is for the supply of an Advair HFA 230-21 MCG inhaler product. The contract has a firm fixed price and an ultimate completion date of June 29, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.58 fixed-price delivery order is for the supply of Advair HFA 45-21 MCG Inhaler, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $1,325.24 firm fixed price delivery order contract has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as...
- This federal contract award, valued at $2,588.42, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of Advair HFA 230-21 MCG Inhaler, a pharmaceutical product, with a completion date of May 3, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense and Veterans...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG inhalers. The contract is a Delivery Order valued at $3,313.10 with a firm fixed price. It has an ultimate completion date of May 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $6,166.31 Firm Fixed Price Delivery Order is for the supply of 4,564,730,985 units of the pharmaceutical product Advair HFA 230-21 MCG Inhaler 12GM. The contract has an ultimate completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Amerisourcebergen Corporation. The $14,745.04 firm fixed-price delivery order is for the supply of an Advair HFA 230-21 mcg inhaler product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB24FBPWZDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award is a Delivery Order for the provision of Advair HFA 230-21 MCG Inhalers, valued at $5,724.02. The contract has a firm fixed price and an ultimate completion date of May 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This award was made on a full and open competition basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 5/28/24 |